Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:50 AM UTC
| NCT Number | NCT06162221 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 616 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Revolution Medicines, Inc. |
| Last Updated on CT.gov | June 30, 2026 (2 weeks ago) |
As of July 17, 2026: Clinical trial NCT06162221 is currently recruiting participants. This phase1 study for lung cancer is actively seeking new participants at 28 locations across the United States. The study is sponsored by Revolution Medicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06162221 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06162221 was last updated 2 weeks ago (June 30, 2026). HelloStudys verifies this status automatically.